Inventor · disambiguated record
Zhixiong Ye
Also filed as: YE ZHIXIONG
25 granted patents·10 pending applications·448 citations·filing 1996–2022
96Inventor score
Top patents by PatentIndex Score
35 records- 0196US10800782B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 13, 2020·8 cites·42 claims
- 0296US6410548B2Spiropiperidine derivatives as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Jun 25, 2002·71 cites·11 claims
- 0396US6350760B1Substituted piperidines as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2000·Granted Feb 26, 2002·102 cites·25 claims
- 0494US11325914B1Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·2 cites·25 claims
- 0593US10329298B2Inhibitors of cellular metabolic processesAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jun 25, 2019·11 cites·32 claims
- 0692US6376509B2Melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Apr 23, 2002·55 cites·27 claims
- 0791US9108921B2Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Granted Aug 18, 2015·22 cites·8 claims
- 0890US6458790B2Substituted piperidines as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Oct 1, 2002·56 cites·29 claims
- 0988US6294534B1Spiropiperidine derivatives as melanocortin receptor agonistsMERCK & CO INC·Filed 1999·Granted Sep 25, 2001·75 cites·15 claims
- 1077USRE49934EInhibitors of cellular metabolic processesSERVIER PHARMACEUTICALS LLC·Filed 2022·Granted Apr 23, 2024·0 cites·45 claims
- 1177US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 1275US7276520B2Bicyclic piperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Oct 2, 2007·8 cites·21 claims
- 1375US6767915B2Substituted piperidines as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Jul 27, 2004·9 cites·29 claims
- 1470US7652024B2Acylated spiropiperidine derivatives as melanocortin-4 receptor modulatorsMERCK SHARP & DOHME·Filed 2006·Granted Jan 26, 2010·2 cites·19 claims
- 1570US7015235B2Acylated piperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2002·Granted Mar 21, 2006·4 cites·12 claims
- 1669US9662327B2Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerCAO SHELDON·Filed 2012·Granted May 30, 2017·2 cites·22 claims
- 1765US10000479B2Compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 19, 2018·1 cites·25 claims
- 1865US7414057B2Piperazine urea derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2003·Granted Aug 19, 2008·2 cites·26 claims
- 1964US7329673B2Acylated spiropiperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·2 cites·22 claims
- 2064US5677467ASynthesis of acetogeninsUNIV MINNESOTA·Filed 1996·Granted Oct 14, 1997·8 cites·10 claims
- 2160US7160886B2Acylated piperazine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Jan 9, 2007·1 cites·31 claims
- 2259US5739358ASynthesis of acetogeninsUNIV MINNESOTA·Filed 1997·Granted Apr 14, 1998·6 cites·7 claims
- 2354US2016046579A1Therapeutic compounds and compositionsCIANCHETTA GIOVANNI·Filed 2014·Application pending·0 cites
- 2454US2024140958A1Fused quadracyclic compounds, compositions and uses thereofTABOMEDEX BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2552US9365545B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2015·Granted Jun 14, 2016·0 cites·31 claims
- 2650US2006035935A1Acylated piperidine derivatives as melanocortin-4 receptor agonistsGOULET MARK T·Filed 2005·Application pending·0 cites
- 2748US2017210749A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2847US2011201615A1Triazole beta carboline derivatives as anti-diabetic agentsGUO LIANGQIN·Filed 2009·Application pending·0 cites
- 2947US2002137664A1Substituted piperidines as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2001·Application pending·0 cites
- 3044US2009253744A1Acylated piperidine derivatives as melanocortin-4 receptor modulatorsBAKSHI RAMAN K·Filed 2007·Application pending·0 cites
- 3143US11963960B2Compounds for treating or inhibiting recurrence of acute myeloid leukemiaFLASH THERAPEUTICS LLC·Filed 2021·Granted Apr 23, 2024·0 cites·19 claims
- 3243US2014213580A1Therapeutically active compositions and their methods of useCAO SHELDON·Filed 2012·Application pending·0 cites
- 3341US7115628B2Bridged piperidine derivatives as melanocortin receptor agonistsMERCK & CO INC·Filed 2002·Granted Oct 3, 2006·0 cites·19 claims
- 3441US2008051430A1Acylated Piperidine Derivatives as Melanocortin 4-Receptor AgonistsBARAKAT KHALED J·Filed 2005·Application pending·0 cites
- 3541US2010184758A1Beta carboline derivatives as antidiabetic compoundsDOBBELAAR PETER H·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →